Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2006 1
2008 1
2009 2
2010 3
2011 1
2013 1
2014 1
2017 1
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Human embryo immune escape mechanisms rediscovered by the tumor.
Ridolfi L, Petrini M, Fiammenghi L, Riccobon A, Ridolfi R. Ridolfi L, et al. Among authors: fiammenghi l. Immunobiology. 2009;214(1):61-76. doi: 10.1016/j.imbio.2008.03.003. Epub 2008 Jun 17. Immunobiology. 2009. PMID: 19159828 Review.
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone.
Bulgarelli J, Fiammenghi L, Cassan S, Granato AM, Petrini M, Pancisi E, Soldati V, De Rosa F, Ridolfi L, Riccobon A, Guidoboni M. Bulgarelli J, et al. Among authors: fiammenghi l. Cytotherapy. 2018 Jun;20(6):851-860. doi: 10.1016/j.jcyt.2018.04.002. Epub 2018 May 10. Cytotherapy. 2018. PMID: 29754770 Free article.
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience.
de Rosa F, Ridolfi L, Fiammenghi L, Petrini M, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Bulgarelli J, Framarini M, Tauceri F, Migliori G, Brolli C, Gentili G, Petracci E, Nanni O, Riccobon A, Ridolfi R, Guidoboni M. de Rosa F, et al. Among authors: fiammenghi l. Melanoma Res. 2017 Aug;27(4):351-357. doi: 10.1097/CMR.0000000000000356. Melanoma Res. 2017. PMID: 28654547
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome.
Ridolfi L, Petrini M, Fiammenghi L, Granato AM, Ancarani V, Pancisi E, Brolli C, Selva M, Scarpi E, Valmorri L, Nicoletti SV, Guidoboni M, Riccobon A, Ridolfi R. Ridolfi L, et al. Among authors: fiammenghi l. Melanoma Res. 2011 Dec;21(6):524-9. doi: 10.1097/CMR.0b013e32834b58fa. Melanoma Res. 2011. PMID: 21909041
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial).
Ridolfi L, de Rosa F, Fiammenghi L, Petrini M, Granato AM, Ancarani V, Pancisi E, Soldati V, Cassan S, Bulgarelli J, Riccobon A, Gentili G, Nanni O, Framarini M, Tauceri F, Guidoboni M. Ridolfi L, et al. Among authors: fiammenghi l. BMJ Open. 2018 Aug 5;8(8):e021701. doi: 10.1136/bmjopen-2018-021701. BMJ Open. 2018. PMID: 30082356 Free PMC article.
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.
Ridolfi L, Petrini M, Granato AM, Gentilcore G, Simeone E, Ascierto PA, Pancisi E, Ancarani V, Fiammenghi L, Guidoboni M, de Rosa F, Valmorri L, Scarpi E, Nicoletti SV, Baravelli S, Riccobon A, Ridolfi R. Ridolfi L, et al. Among authors: fiammenghi l. J Transl Med. 2013 May 31;11:135. doi: 10.1186/1479-5876-11-135. J Transl Med. 2013. PMID: 23725550 Free PMC article.
Evaluation of in vivo labelled dendritic cell migration in cancer patients.
Ridolfi R, Riccobon A, Galassi R, Giorgetti G, Petrini M, Fiammenghi L, Stefanelli M, Ridolfi L, Moretti A, Migliori G, Fiorentini G. Ridolfi R, et al. Among authors: fiammenghi l. J Transl Med. 2004 Jul 30;2(1):27. doi: 10.1186/1479-5876-2-27. J Transl Med. 2004. PMID: 15285807 Free PMC article.
15 results